(Q39665713)

13 September 2017

1 reference

title

Pharmacokinetics of long acting propranolol. Implications for therapeutic use. (English)

1 reference

13 September 2017

1 reference

G S Nace

1

1 reference

PubMed ID

3304770

13 September 2017

A J Wood

series ordinal

2

1 reference

13 September 2017

1 July 1987

1 reference

Clinical Pharmacokinetics

13 September 2017

1 reference

13 September 2017

13

1 reference

13 September 2017

1

1 reference

13 September 2017

51-64

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-198713010-00003

13 September 2017

0 references

cites work

Dose response effectiveness of propranolol for the treatment of angina pectoris

1 reference

12 December 2020

Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactions

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic studies with long-acting propranolol

1 reference

12 December 2020

Propranolol in angina pectoris. Comparison of long-acting and standard-formulation propranolol

1 reference

12 December 2020

Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol

1 reference

12 December 2020

Duration of action of beta blockers

1 reference

12 December 2020

Single daily dosing of propranolol in hypertension

1 reference

12 December 2020

One and three doses of propranolol a day in hypertension

1 reference

12 December 2020

Propranolol LA and ambulatory blood pressure

1 reference

12 December 2020

A study of long acting propranolol in the early management of hyperthyroidism

1 reference

12 December 2020

Beta-adrenergic blockade. An update

1 reference

12 December 2020

Combined High-performance Liquid Chromatographic Procedure for Measuring 4-hydroxypropranolol and Propranolol in Plasma: Pharmacokinetic Measurements Following Conventional and Slow-Release Propranolol Administration

1 reference

12 December 2020

Effect of metoclopramide on the bioavailability of long‐acting propranolol

1 reference

12 December 2020

Comparative Bioavailability of Propranolol: Twice‐Daily Versus Four Times‐Daily Administration

1 reference

12 December 2020

Drug Defaulting in a General Practice

1 reference

12 December 2020

Comparison between atenolol and nadolol in essential hypertension at rest and on exercise

1 reference

12 December 2020

Correlation between propranolol in plasma and urine, renin-aldosterone system and blood pressure in essential hypertension

1 reference

12 December 2020

Direct measurement of propranolol bioavailability during accumulation to steady-state

1 reference

12 December 2020

Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris

1 reference

12 December 2020

Effect of beta blockade with betaxolol on left ventricular systolic function in chronic stable angina pectoris and left ventricular dysfunction.

1 reference

12 December 2020

Atenolol: once-daily cardioselective beta blockade for angina pectoris

1 reference

12 December 2020

Propranolol: pooled Michaelis-Menten parameters and the effect of input rate on bioavailability.

1 reference

12 December 2020

Relationship of propranolol pharmacokinetics to antihypertensive effect and beta-adrenergic blockade in the treatment of hypertension

1 reference

12 December 2020

Propranolol dosage, plasma concentration, and beta blockade

1 reference

12 December 2020

Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol

1 reference

12 December 2020

Side-effects of beta-adrenoceptor blocking drugs assessed by visual analogue scales

1 reference

12 December 2020

Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris

1 reference

12 December 2020

Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension

1 reference

12 December 2020

Comparison of sustained-release clonidine and long-acting propranolol in the treatment of hypertension

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacological actions of a long-acting formulation of propranolol

1 reference

12 December 2020

Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing

1 reference

12 December 2020

The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension

1 reference

12 December 2020

The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased

1 reference

12 December 2020

Comparative effects of long-acting and conventional propranolol on stress-induced angina pectoris and on frequency of ventricular premature beats

1 reference

12 December 2020

Effect on exercise tolerance and pharmacokinetics of conventional and sustained release preparations of propranolol in patients with angina pectoris--a double-blind cross-over study

1 reference

12 December 2020

Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol

1 reference

12 December 2020

Long-acting propranolol in essential tremor

1 reference

12 December 2020

Clinical Pharmacokinetics of Propranolol

1 reference

12 December 2020

Beta-blockers and sleep: a controlled trial

1 reference

12 December 2020

The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients

1 reference

12 December 2020

Comparative pharmacokinetics of propranolol and 4-hydroxypropranolol using conventional and long-acting propranolol

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic studies with a new controlled-release formulation of propranolol in normal volunteers: a comparison with other commercially available formulations

1 reference

12 December 2020

Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.

1 reference

12 December 2020

Once daily administration of sustained release propranolol capsules in the treatment of angina pectoris

1 reference

12 December 2020

Studies with long acting propranolol

1 reference

12 December 2020

10.2165/00003088-198713010-00003

Identifiers

DOI

1 reference

PubMed ID

3304770

Dimensions Publication ID

13 September 2017

0 references

1 reference

PubMed ID

3304770